Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

Gwennaelle Marin

Department : Nuclear medicine
Speciality : Radiophysics
 
gwennaelle.marin [at] hubruxelles.be

Publications

Understanding the Radiobiological Mechanisms Induced by (177)Lu-DOTATATE in Comparison to External Beam Radiation Therapy.

Authors : Delbart W, Karabet J, Marin G, Penninckx S, Derrien J, Ghanem GE, Flamen P, Wimana Z
Year : 2022
Journal : Int J Mol Sci

Dual [(68)Ga]DOTATATE and [(18)F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.

Authors : Chan DL, Hayes AR, Karfis I, Conner A, Furtado OMahony L, Mileva M, Bernard E, Roach P, Marin G, Pavlakis N, Schembri G, Gnanasegaran G, Marin C, Vanderlinden B, Navalkissoor S, Caplin ME, Flamen P, Toumpanakis C, Bailey DL
Year : 2022
Journal : Br J Cancer

Personalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report.

Authors : Herchuelz M, Marin G, Derijckere ID, Vouche M, Delatte P, Donckier V, Liberale G, Hendlisz A, Artigas C, Bourgeois P, Flamen P
Year : 2020
Journal : Radiol Case Rep

Prognostic value of a three-scale grading system based on combining molecular imaging with <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias.

Authors : Karfis I, Marin G, Levillain H, Drisis S, Muteganya R, Critchi G, Taraji-Schiltz L, Guix CA, Shaza L, Elbachiri M, Mans L, Machiels G, Hendlisz A, Flamen P
Year : 2020
Journal : Oncotarget

A dosimetry procedure for organs-at-risk in <sup>177</sup>Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours.

Authors : Marin G, Vanderlinden B, Karfis I, Guiot T, Wimana Z, Reynaert N, Vandenberghe S, Flamen P
Year : 2018
Journal : Phys Med

More publications »